Overview
- 3 inspections across 3 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2017-05-23.
At a glance
Inspections
3
Sites
3
Observations
0
Career since
May 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Rentschler Biopharma SE | 23 May 2017 | Human Drugs | On file |
| Genentech Inc | 26 Aug 2016 | Human Drugs | On file |
| Sanofi-Aventis Deutschland GmbH | 13 May 2016 | Human Drugs |
Sites inspected
Rentschler Biopharma SELaupheim, Germany1 insp.
Genentech IncVacaville, United States1 insp.
Sanofi-Aventis Deutschland GmbHFrankfurt Am Main, Germany1 insp.
Co-investigators
Investigators who share inspections with this person.
Maria J Lopez- Barragan1 shared
Maxwell L Van Tassell1 shared
Diane L Raccasi1 shared
Reyes Candau-Chacon1 shared
Steven Fong1 shared
Stephanie A Slater1 shared
Full investigator report
Get the verbatim findings behind Ruth A Moore's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site